QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH Continues to Demonstrate Effectiveness in Lab Testing
Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) patented drug-delivery platform, DehydraTECH, has exhibited continued success in recent animal lab tests by delivering cannabinoids to the bloodstream faster than conventional cannabinoid formulations (http://ibn.fm/pYSzq). A recent article discussing the company reads, “Lab tests and actual licensed use in the cannabis industry have proved that DehydraTECH’s long-chain fatty acid (“LCFA”) formulation is able to deliver cannabinoids faster than formulations with medium-chain triglyceride (“MCT”) oils, such as coconut oil. DehydraTECH also offers the most advanced flavor and aroma-profile masking techniques in the industry. The groundbreaking technology could negate the need for artificial chemical masking agents…